[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9900 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 9900

 To modify the National Security Commission on Emergency Biotechnology.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            October 1, 2024

  Mr. Khanna introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
 To modify the National Security Commission on Emergency Biotechnology.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``BioTech Innovation and National 
Security Continuation Act''.

SEC. 2. MODIFICATION OF NATIONAL SECURITY COMMISSION ON EMERGING 
              BIOTECHNOLOGY.

    Section 1091 of the National Defense Authorization Act for Fiscal 
Year 2022 (Public Law 117-81) is amended--
            (1) in subsection (b)(3) by striking ``the authority to 
        make such appointment or appointments shall expire, and the 
        number of members of the Commission shall be reduced by the 
        number equal to the number of appointments so not made'' and 
        inserting ``such appointments shall nevertheless be considered 
        valid'';
            (2) in subsection (g)(1), by inserting ``and 6 months'' 
        after ``3 years''; and
            (3) in subsection (r), by striking ``18 months after the 
        date on which it submits the final report required by 
        subsection (g)'' and inserting ``on December 31, 2026''.
                                 <all>